SP
Shilpa Pharma Lifesciences Ltd
CDMO · Raichur, India
GMP
Overview
Shilpa Pharma Lifesciences, trading as Shilpa CDMO, is the wholly owned API subsidiary of Shilpa Medicare and runs an export-oriented campus in Raichur, Karnataka. It makes small molecules, peptides, HPAPIs, ADC linkers and polymers and offers development through commercial manufacturing. It holds active US Type II DMFs for desmopressin, liraglutide and octreotide. The US FDA inspected Unit-2 in March 2025 with no Form 483 observations.
Capabilities
- Peptide API manufacturing
- Contract development and manufacturing
- HPAPI
- ADC linkers and payloads
- Analytical services
Quality signals
| GMP evidence | Yes |
|---|---|
| Certificates of analysis | Not found |
| Third-party testing | Not found |
| ISO certification | Not found |
| Makes own product | Yes, in-house production |